Australian Cancer Research Foundation (ACRF)
In 
2010, the Australian Cancer Research Foundation (ACRF) committed $2 million to support two new cancer research groups at the Walter and Eliza Hall Institute.
The funding has helped to fit-out the institute’s ACRF Stem Cells and Cancer division and the ACRF Chemical Biology division, which will be officially opened in late 2012. These divisions will expand the institute’s research programs into the causes of, and new treatments for, some of the most prevalent cancers in Australia, including breast cancer, ovarian cancer, lung cancer, and leukaemia.
The ACRF Stem Cells and Cancer division will study the biology of epithelial cancers, including breast, lung, ovarian and prostate cancer. Epithelial cancers account for about 80 per cent of human cancers and new treatments are desperately needed.
The new funding will also support researchers in the ACRF Chemical Biology division to develop new medications for cancers including epithelial cancers and blood cancers such as leukaemia.